No Data
No Data
ClearPoint Neuro, Inc. (CLPT): A Bear Case Theory
ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024
Daiwa Heavy Report: Will brain-computer interface be the next major medical technology opportunity?
It is stated by DaMo that BCI technology may become an important breakthrough in future medical technology, providing new treatment options for nearly 10 million BCI candidates (patients with neurological diseases), and bringing about a $400 billion market opportunity.
Market Participants Recognise ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Revenues Pushing Shares 28% Higher
Hain Celestial Posts Upbeat Q4 Earnings, Joins Soleno Therapeutics, Energizer Holdings And Other Big Stocks Moving Higher On Tuesday
ClearPoint Neuro Shares Are Trading Higher After the Company Announced the Early Repayment of a $10 Million Convertible Note to PTC Therapeutics. Additionally, Lake Street Raised Its Price Target on the Stock From $11 to $15.